tradingkey.logo

iSpecimen Inc

ISPC
View Detailed Chart

1.410USD

-0.140-9.03%
Close 09/19, 16:00ETQuotes delayed by 15 min
3.52MMarket Cap
LossP/E TTM

iSpecimen Inc

1.410

-0.140-9.03%
Intraday
1m
30m
1h
D
W
M
D

Today

-9.03%

5 Days

-27.69%

1 Month

+27.03%

6 Months

+6.02%

Year to Date

-46.89%

1 Year

-70.25%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is very high. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
250 / 470
Overall Ranking
474 / 4720
Industry
Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.
Growing
The company is in a growing phase, with the latest annual income totaling USD 9.29M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 21.98.
Undervalued
The company’s latest PE is -0.16, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 133.51K shares, decreasing 25.29% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.24K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.
Ticker SymbolISPC
CompanyiSpecimen Inc
CEOMr. Robert Bradley Lim
Websitehttps://www.ispecimen.com/
KeyAI